Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Agios Pharmaceuticals Insider Sold Shares Worth $296,470, According to a Recent SEC Filing

Agios Pharmaceuticals Insider Sold Shares Worth $296,470, According to a Recent SEC Filing

MT newswireMT newswire2026/10/28 20:27
04:27 PM EDT, 10/28/2026 (MT Newswires) -- Sarah Gheuens, Chief Medical Officer, on October 26, 2026, sold 7,866 shares in Agios Pharmaceuticals (AGIO) for $296,470. Following the Form 4 filing with the SEC, Gheuens has control over a total of 54,645 common shares of the company, with 54,645 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1439222/000143922226000124/xslF345X05/wk-form4_1793217741.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion

Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.

智通财经•2026/11/10 04:31

Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output

Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.

智通财经•2026/11/10 04:12